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Objectives. The present study was designed to assess the impact
of direct current shocks on cardiac troponin I (cTnI), which has
greater sensitivity and specificity than creatine kinase (CK) for
the diagnosis of myocardial injury.
Background. Transthoracic direct current shocks can cause
myocardial injury. They also cause elevations of total CK and
CK-MB fraction (CK-MB).
Methods. We obtained measurements of cTnI total CK and
CK-MB before and after elective cardioversions in 38 patients.
Blood samples were drawn before and 8, 16, 24 and 48 h after
cardioversion. Shock energy, current, impedance and number of
shocks delivered were tabulated.
Results. Patients received a mean (6SD) of 2.1 6 1.2 shocks
with a median cumulative energy of 300 J (range 50 to 1,580).
Three patients had minimal elevations (1.5, 1.2 and 0.8 ng/ml,
normal <20.6 ng/ml) of cTnI. Two of these patients had impaired
left ventricular contractility by echocardiography. Thirty-five of
the 38 patients had no elevations of cTnI. Sixty-two percent of
patients had an increase in CK after cardioversion, but CK-MB
was elevated to an abnormal level of 12.7 ng/ml (normal <6.7) in
only one patient after cardioversion.
Conclusions. Cardiac troponin I levels are either normal or
minimally elevated after elective direct current cardioversion,
suggesting that subtle myocardial injury can be caused by direct
current transthoracic shocks. However, substantial elevations of
cTnI after cardioversion suggest the presence of myocardial injury
from causes unrelated to the direct current shocks administered
for cardioversion.
(J Am Coll Cardiol 1997;30:1052–6)
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High energy direct current transthoracic shocks have been
reported to cause elevations of total creatine kinase (CK) and
CK-MB fraction (CK-MB). Determining whether elevations of
CK-MB result from myocardial as opposed to skeletal muscle
injury can be difficult (1–4). Because there is a higher percent-
age of CK-MB in myocardial muscle, the measurement of
CK-MB as a percentage of total CK has been advocated to
improve specificity for cardiac injury. However, this approach
has the effect of decreasing sensitivity, especially when con-
comitant skeletal muscle injury is present (5–8).
Cardiac troponin I (cTnI) is a cardiac regulatory protein
found only in cardiac muscle (7). It is a sensitive and specific
marker of myocardial injury (7–13). Unlike total CK and
CK-MB, cTnI is not liberated by skeletal muscle injury. As
such, it has been demonstrated to be highly specific for
myocardial injury in patients with skeletal muscle injury and
chronic renal failure, as well as in the perioperative period
(7–13). Thus, cTnI should facilitate delineation between skel-
etal muscle and cardiac injury in patients undergoing cardio-
version.
The effect of direct current transthoracic shocks on cTnI
values has not been reported. Therefore, diagnostic confusion
could result when patients with coronary artery disease receive
transthoracic shocks and have elevations of cTnI. Our purpose
was to determine if elective transthoracic direct current shocks
cause elevations of cTnI levels.
Methods
Patients. A total of 38 patients were studied: 21 patients at
the University of Iowa and 17 at Barnes Hospital of Washing-
ton University, St. Louis, Missouri. Patients were recruited if
they received direct current transthoracic shocks for elective
cardioversion (n 5 35) or for termination of ventricular
tachycardia induced during provocative electrophysiologic
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testing (n 5 3). Patients were excluded from entry into the
study if they had a myocardial infarction, unstable angina or a
coronary intervention (coronary artery bypass graft surgery,
percutaneous transluminal coronary angioplasty, stent place-
ment or atherectomy) within 10 days of cardioversion, because
cTnI levels can remain elevated for over a week after cardiac
injury (14).
Clinical and laboratory evaluations. After written in-
formed consent, the patients’ charts were reviewed. Age,
gender and major diagnoses were recorded. Baseline CK,
CK-MB and cTnI levels were measured. Postshock CK,
CK-MB and cTnI levels were obtained at 8, 16, 24 and 48 h
when the patient’s hospital stay was sufficiently long to allow
this.
Standard cardioversion shock energy protocols were fol-
lowed. Initial selected energies were 50 J for atrial flutter and
100 J for either atrial fibrillation or ventricular tachycardia,
with stepwise increases to a maximum of 360 J as judged
appropriate by the clinician in charge of the patient’s care. All
cardioversions were done using Hewlett-Packard defibrillators
(various models) with electrodes placed in the apex-anterior or
anteroposterior configuration. Either hand-held electrode pad-
dles or self-adhesive monitor-defibrillator electrode pads were
used. The type and position of the electrodes used were
determined by the clinician in charge of the patient, and was
not controlled.
The number of shocks and operator-selected energy given
to each patient was recorded. In addition, transthoracic im-
pedance, peak current and actual delivered energy of each
shock were recorded in 10 patients studied at the University of
Iowa using a Hewlett-Packard “Codemaster” defibrillator that
automatically provides this information.
Both CK-MB and cTnI were measured using a Stratus
Intellect immunoassay analyzer (Dade). Samples were frozen
at 220°C before analysis and assayed within 12 h of venipunc-
ture. The assays are two-site enzyme immunoassays utilizing
monoclonal antibodies to either CK-MB or cTnI. The level of
detectability for cTnI is 0.4 ng/ml. The upper limit of the
reference range is 0.6 ng/ml (14).
Statistics. Mean values 6 SD were calculated for the main
variables; medians were determined for variables with skewed
distributions. Pearson correlation coefficients were calculated
for linear associations of continuous variables, and Spearman
correlation coefficients (rho) for ranked data. To test for the
difference in cTnI at baseline and after cardioversion, a paired
t test was conducted, followed by repeated measures analysis of
variance with adjustment for covariates such as number of
transthoracic shocks, peak energy and cumulative energy. The
Wilcoxon signed-rank test was used to test for the difference in
CK at baseline and after cardioversion. Alpha was set at 0.05
(two-tailed). All calculations were performed using standard
procedures in SYSTAT.
Results
Patients. The clinical characteristics of the patients studied
are shown in Table 1. Patients received from one to five shocks,
with one shock being the most frequent (41% of patients) and
five the least (3%). The mean (6SD) number of shocks was
2.1 6 1.2. Cumulative energy was positively skewed with a
median of 300 J (range 50 to 1,580) (Table 2). Normal sinus
rhythm was restored in 32 of 35 patients with atrial fibrillation
or atrial flutter and all of the three patients with ventricular
tachycardia.
Over half of the patients (62%) experienced an increase in
CK after cardioversion. The mean CK increase was 633 6
1,827 IU/liter; because the data are skewed, the median
increase was 9 IU/liter, with a range of 257 to 1,857 IU/liter
(Table 2). The median CK at baseline was 68 IU/liter (range 16
to 647) and the median postcardioversion value was 86 IU/liter
(range 20 to 9,025). In four patients, there was an increase of
more than 2,000 IU/liter from baseline. The difference in CK
from precardioversion to postcardioversion was statistically
significant (p 5 0.038). However, only one patient had an
increase in CK-MB above normal, to 12.7 ng/nl (normal ,6.7).
The relation between cumulative energy and change in CK
was not linear but showed evidence of a correlation when
ranked (rs 5 0.668, p , 0.001). In the 10 patients in whom
current was measured, there was no significant linear relation
Abbreviations and Acronyms
CK 5 creatine kinase
CK-MB 5 creatine kinase-MB fraction
cTnI 5 cardiac troponin I
Table 1. Clinical Characteristics of 38 Study Patients
Age (yr) 65 6 9
Men/women 26/12
Arrhythmia
Atrial fibrillation 27
Atrial flutter 8
Ventricular tachycardia (induced in electrophysiology laboratory) 3
Serum creatinine .2.0 mg/dl 3
Echocardiographic findings (33 of 38 patients)
Impaired left ventricular systolic function 13
Increased left ventricular end-diastolic dimension 4
Left ventricular hypertrophy 6
Left atrial enlargement 14
Data are presented as mean value 6SD or number of patients.
Table 2. Number of Shocks, Peak Selected Energy and Cumulative
Energy and Creatine Kinase Increase Over Baseline
No. of
Shocks
Peak Selected
Energy (J)
Cumulative
Energy (J)
CK Increase
Over Baseline
(IU/liter)
Mean 6 SD 2.1 6 1.2 212 6 95 370 6 310 633 6 1,827
Median 2.0 200 300 9.0
Range 1–5 50–360 50–1,580 257–8,957
CK 5 creatine kinase.
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(p 5 0.458) between peak current and total change in CK, nor
was there a significant ranked correlation (rs 5 0.595, p .
0.10).
Table 3 shows the peak current, impedance and actual
delivered energy in 10 patients undergoing cardioversion at the
University of Iowa, using number of shocks with defibrillators
to annotate this information.
There was no statistically significant change in cTnI before
and after shock (p 5 0.276). Adjustment for cumulative
energy, peak energy or difference in CK over baseline did not
affect this result. Three patients had elevations of cTnI to
values of 1.5, 1.2 and 0.8 ng/ml (normal #0.6). The patient with
a cTnI level of 1.2 ng/ml was also the only patient with an
elevated CK-MB. None of these three patients had any clinical
events or electrocardiographic evidence to suggest myocardial
infarction. These three patients received a mean (6SD) of
1.7 6 1.2) shocks, with a median cumulative energy of 200
IU/liter, similar to all the patients (2.1 6 1.2 shocks). The peak
selected energy of these three patients was 200 6 100 J), also
similar to that of the entire patient group (212 6 95 J). Two of
these three patients had impaired left ventricular systolic
function by precardioversion echocardiography compared with
11 of 30 patients who had no cTnI elevation after cardiover-
sion. Left ventricular end-diastolic diameter was normal in all
three patients who displayed cTnI elevation after cardioversion.
Discussion
The major finding of our study is that minor elevations of
cTnI reflecting subtle myocardial injury can occur during
elective cardioversion, but they are uncommon. Substantial
elevations of cTnI do not occur.
Three of our patients showed cTnI elevations; 35 of our 38
patients did not. However, we were careful to exclude patients
with cardiac events in the 10 days before cardioversion because
elevations of troponin persist in plasma for a median of 7 days
after myocardial injury (14). We also insisted that each patient
have a normal baseline value of cTnI. Unless such precautions
are followed, cTnI elevations are likely to be encountered
more frequently and may be of a larger magnitude.
Elevations of total CK were common and were significantly
increased after cardioversion, with a mean increase of 633 6
1,827 IU/liter over baseline. This is not unexpected and is
consistent with previous reports of high CK values after high
energy transthoracic shocks (1–3). However, of the three
patients with cTnI elevations, CK-MB values were elevated in
only one. This patient had no clinical symptoms or electrocar-
diographic evidence of infarction, but did have impaired left
ventricular systolic function by precardioversion echocardiog-
raphy. He received three shocks totaling 600 J, which termi-
nated his atrial fibrillation.
A second patient had an elevated cTnI level of 1.5 ng/ml at
24 h and 1.3 ng/ml at 48 h. He was admitted to the hospital for
severe congestive heart failure requiring inotropic support and
was in atrial fibrillation. He had received one successful 200-J
shock. He did not have a significant increase in CK-MB or
clinical or electrocardiographic evidence of infarction. The
reason for his elevated value of cTnI is likely multifactorial.
Recent data suggest that patients with congestive heart failure
have higher levels of cTnI than normal subjects. Missov et al.
(15) studied 11 patients with end-stage congestive heart failure
and found circulating levels of cTnI in 10, levels which were
higher than those of any of their control subjects. However, all
of them had levels of cTnI below the level of detection of the
assay used for this study. Nonetheless, patients with congestive
heart failure may have subtle ongoing myocardial injury that
might make them more susceptible to damage induced by
direct current shock energy. Two of our patients with increased
cTnI had impaired left ventricular function by echocardiogra-
phy, and one, as noted, had clinical congestive heart failure.
The final patient with an elevation of cTnI did not have
heart failure or any other reason for an elevated cTnI apart
from the direct current shock. He received one shock of 100 J,
which terminated his atrial flutter.
Current and impedance measurements were not available
from any of the three patients with cTnI elevations; we cannot
exclude the possibility that these three patients had lower
transthoracic impedance and thus received more current than
the others.
The fact that minor degrees of myocardial injury can be
induced by electrical shocks should not be surprising. Myocar-
dial injury has been demonstrated after direct current shocks
both histologically and by enzyme analysis in experimental
studies (1–4). The mechanism of this injury is uncertain.
Heat-induced necrosis has been suggested as a possible cause
(16), but is not universally accepted (17). Electroporation (the
increase in permeability of the cellular membrane in response
to pulsed electric fields) occurs after direct current shocks, and
it too has been proposed as a potential mechanism (17).
Electroporation has been shown to be dependent on pulse
duration, voltage, number of pulses applied and time between
pulses (18). In addition, a reduction in mitochondrial oxygen
consumption after direct current shocks has been observed and
hypothesized to be due to intracellular calcium flux, high
circulating catecholamines or free radical generation (18).
However, pretreatment with beta-blockers and calcium chan-
nel blockers does not reduce direct current shock-induced
myocardial damage (19). Free radicals, which are known to be
toxic to the myocardium, also are known to be generated by
direct current shocks (20). Caterine et al. (20) showed that free
radical generation was proportional to the magnitude of the
shock energy and that the free radical scavengers superoxide
dismutase and catalase reduced this free radical generation
Table 3. Number of Shocks, Peak Delivered Energy, Peak Current
and Transthoracic Impedence in 10 Patients*
No. of
Shocks
Peak Delivered
Energy (J)
Impedance
(V)
Peak Current
(A)
Mean 6 SD 1.7 6 1.2 228 6 119 72 6 23 34 6 9
Range 1–4 47–378 40–116 21–47
*Patients undergoing cardioversion at the University of Iowa.
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(21). Thus, regardless of the mechanism, minor degrees of
myocardial injury were not unexpected.
Elevations of cTnI in patients with acute infarction. Im-
portantly, these minor cTnI elevations should not lead to
diagnostic confusion with possible ischemic cardiac injury. In a
recent series of 163 patients with acute infarction, the mean
peak cTnI value ranged from 7.7 to 33.7 ng/ml depending on
the type of infarction. Although there was an occasional
patient with a mean value ,1 ng/ml among patients with
non–Q wave infarction, such minor elevations were rare (14).
Accordingly, elevations .1.5 ng/ml (the highest value in our
series) should be considered indicative of cardiac injury from a
cause other than the elective cardioversion.
Previous studies of cardioversion. A positive relation be-
tween total CK increase and cumulative energy has been noted
previously (2,3), but not consistently (1). We did not observe a
linear relation, but we did find a significant positive correlation
when the data were ranked. Although this may in part be due
to low patient numbers, it is clear that the relation between CK
release from skeletal and cardiac muscle and direct current
shocks is dependent on many variables in addition to shock
energy. For example, Dahl et al. (22) demonstrated that the
shorter the time between successive shocks, the greater the
myocardial damage. Furthermore, for transthoracic defibrilla-
tion, greater myocardial damage occurs when using smaller
electrode sizes (23). Some, if not all, of these principles may
apply to skeletal muscle injury as well. Therefore, it is not
surprising that a high correlation between cumulative energy
and CK increase was not observed.
Our findings with regard to CK-MB after cardioversion are
similar to those of other investigators. Ehsani et al. (1) studied
35 patients receiving direct current countershocks. They found
that 50% of their patients had an elevated peak CK, whereas
only two patients had modest elevations of CK-MB. They
concluded that “conventionally used countershock does not
produce myocardial damage, although myocardial injury suffi-
cient to release small amount of MB creatine kinase into the
circulation appears to occur occasionally” (1). Unfortunately,
at the time of that study, techniques such as the use of cTnI
were not available to help distinguish skeletal muscle from
cardiac muscle release of CK-MB.
Jakobsson et al. (2) studied 30 patients cardioverted for
atrial fibrillation. Seven of them had elevations of CK-MB.
None of these seven patients had an elevation of the CK-MB
to CK ratio, which is a criterion that improves the specificity
for CK-MB release for cardiac injury, but at the expense of
sensitivity. Metcalfe et al. (4) examined 25 patients cardio-
verted for atrial fibrillation. Creatine kinase, MB fraction was
elevated in six patients, “appreciably so” in only two patients.
These two patients also had a high total CK, and thus a low
percentage of CK-MB relative to total CK.
Although experimental studies have shown that myocardial
damage increases with increasing shock strength (16), there
was no correlation in our data set between peak current and
total CK increase in the 10 patients in whom current was
measured. In addition, the three patients with elevated cTnI
levels received numbers of shocks and cumulative and peak
energies similar to those of the patients without cTnI elevations.
Conclusions. Three of 38 patients undergoing elective car-
dioversion had mildly elevated cTnI levels after the procedure.
The fact that there is no cross reactivity between cTnI and
skeletal muscle troponin I means that these elevations were
due to subtle degrees of myocardial injury. However, these
minor postcardioversion elevations should not mask concom-
itant myocardial infarction or cause diagnostic confusion;
substantial elevation of cTnI after defibrillation should suggest
the presence of myocardial injury from causes unrelated to
direct current shocks.
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